ENTITY
SK Bioscience

SK Bioscience (302440 KS)

165
Analysis
Health CareSouth Korea
SK Bioscience Co.,Ltd. operates biopharmaceutical businesses. The Company produces vaccines, sky cellflu prefilled syringes, sky cellflu quadrivalent prefilled syringes, varicella drugs, and other related products. SK Bioscience markets its products throughout South Korea.
more
Refresh
01 Jun 2021 13:04

Why I Estimate Total Local Passive Money Tracking KOSPI 200 at ₩80T? Here Is a Breakdown

This post provides a detailed breakdown of how I arrive at an estimated ₩80 trillion for the passive money tracking KOSPI 200.

Logo
358 Views
Share
25 May 2021 20:28

KOSPI 200, KOSDAQ 150, & KRX 300 Indices Rebalance Changes - May 2021

In this insight, we discuss the implications of the additions and deletions of KOSPI 200, KOSDAQ 150, & KRX 300 on the Korean stock market.

Logo
690 Views
Share
25 May 2021 17:11

KOSPI200 Index Rebalance: Spot On!

There are 5 adds and 7 deletes for the KOSPI200 (as we forecast). There could be another add/delete if SK IE Tech gets index Fast Entry. Inclusions...

Logo
550 Views
Share
25 May 2021 16:37

KOSPI 200 Rebalancing: Changes, Passive Flow, & Trade Approach

The KRX has just announced the results of the KOSPI 200 semi-annual rebalancing. This post examines the passive flow of the adds and deletes as...

Logo
299 Views
Share
bearishSD Biosensor
21 May 2021 00:19

SD Biosensor IPO Valuation Analysis

Our base case valuation of SD Biosensor is 82,021 won, which is 4% lower than the high end of the IPO price range of 85,000 won. Given the lack of...

Logo
374 Views
Share
x